Iodine Software
Clinical AI for documentation integrity and utilization review
Our take
Iodine Software, founded in Austin in 2010 by William Chan and Mike Kadyan, applies machine learning to hospital mid-revenue-cycle work. Its AwareCDI suite reads clinical evidence to surface inpatient cases where documentation does not support the acuity of care delivered, prioritizing clinical documentation integrity reviews and physician queries so hospitals capture earned revenue before billing. AwareUM does similar prioritization for utilization management and medical necessity review. Buyers are CDI, HIM, case management, and revenue integrity leaders at hospitals and health systems.
Iodine's models are trained on one of the industry's largest clinical datasets, representing more than a third of all US inpatient discharges, and the company reports more than 900 hospitals using AwareCDI with over $1.5 billion in earned revenue captured. Advent International led its prior ownership until Waystar agreed in July 2025 to acquire the company for $1.25 billion in cash and stock, closing the deal in fall 2025. Inside Waystar, Iodine's clinical intelligence is being combined with a payments platform used by roughly one million providers to prevent denials and reduce manual work.
What it does
- AI-prioritized clinical documentation integrity reviews (AwareCDI)
- Utilization management and medical necessity review (AwareUM)
- Physician query workflows
- Revenue leakage detection before billing
- Denial prevention through documentation accuracy
Where it's strong
- Clinical AI trained on one of the industry's largest datasets, covering more than a third of US inpatient discharges.
- Proven at scale, with more than 900 hospitals using AwareCDI and over $1.5B in earned revenue captured.
- Waystar ownership connects its clinical intelligence to a large healthcare payments platform serving about one million providers.
What buyers should weigh
- Post-acquisition roadmap and pricing now sit inside Waystar, which may matter if you use a competing clearinghouse or RCM vendor.
- Built for inpatient hospital workflows; it is not aimed at ambulatory practices or physician groups.
- CDI and UM programs still need trained clinical staff; the software prioritizes work rather than eliminating it.
Latest
Waystar acquired Iodine Software for $1.25 billion in a deal announced July 2025 and completed in fall 2025.
Also in Revenue Integrity & Pre-Bill Review
SmarterDx
Pre-bill AI review that finds missed revenue and quality
Regard
AI that surfaces undocumented diagnoses in the workflow
Accuity
Physician-led pre-bill chart review that recovers earned revenue
Evidently
EHR-embedded AI that turns scattered chart data into answers
Track this market
First Pass covers Revenue Integrity & Pre-Bill Review and the rest of the getting-paid stack every week.